Journal of Vascular Surgery
Volume 52, Issue 6 , Pages 1450-1457, December 2010

Stent graft-induced new entry after endovascular repair for Stanford type B aortic dissection

Presented at the 2009 Vascular Annual Meeting of the Society for Vascular Surgery, June 11-14, 2009, Denver, Colo.

  • Zhihui Dong, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Weiguo Fu, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
    • Corresponding Author InformationCorrespondence: Wei Guo Fu, MD, Department of Vascular Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai 200032, China
  • ,
  • Yuqi Wang, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Chunsheng Wang, MD

      Affiliations

    • Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Zhiping Yan, MD

      Affiliations

    • Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Daqiao Guo, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Xin Xu, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
  • ,
  • Bin Chen, MD

      Affiliations

    • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

Received 3 February 2010; accepted 22 May 2010. published online 27 August 2010.

Background

Stent graft-induced new entry (SINE), defined as the new tear caused by the stent graft and excluding those arising from natural disease progression or iatrogenic injury from the endovascular manipulation, has been increasingly observed after thoracic endovascular aortic repair (TEVAR) for Stanford type B dissection in our center. SINE appears to be remarkably life threatening. We investigated the incidence, mortality, causes, and preventions of SINE after TEVAR for Stanford type B dissection.

Methods

Data for 22 patients with SINE were retrospectively collected and analyzed from 650 patients undergoing TEVAR for type B dissection from August 2000 to June 2008. An additional patient was referred to our center 14 months after TEVAR was performed in another hospital. The potential associations of SINE with Marfan syndrome, location of SINE and endograft placement, and the oversizing rate were analyzed by Fisher exact probability test or t test.

Results

We found 24 SINE tears in 23 patients, including SINE at the proximal end of the endograft in 15, at the distal end in 7, and at both ends in 1. Six patients died. SINE incidence and mortality reached 3.4% and 26.1%, respectively. Two SINE patients were diagnosed with Marfan syndrome, whereas there were only 6 Marfan patients among the 651 patients. The 16 proximal SINEs were evidenced at the greater curve of the arch and caused retrograde type A dissection. The eight distal SINEs occurred at the dissected flap, and five caused enlarging aneurysm whereas three remained stable. The endograft was placed across the distal aortic arch during the primary TEVAR in all 23 patients. The incidence of SINE was 33.33% among Marfan patients vs 3.26% among non-Marfan patients (P = .016). There was no significant difference in mortality between proximal and distal SINE (25% vs 28.6%, P > .99), incidence of SINE between endograft placement across the arch and at the straight portion of descending thoracic aorta (23 of 613 vs 0 of 38, P = .39), and the oversizing rate between SINE and non-SINE patients (13% ± 4.5% vs 16% ± 6.5%, P = .98).

Conclusions

SINE appears not to be rare after TEVAR for type B dissection and is associated with substantial mortality. The stress yielded by the endograft seems to play a predominant role in its occurrence. It is important to take this stress-induced injury into account during both design and placement of the endograft.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Sponsored by the Program of Shanghai Subject Chief Scientist (Grant Code: 08XD1401200).

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)01563-6

doi:10.1016/j.jvs.2010.05.121

Journal of Vascular Surgery
Volume 52, Issue 6 , Pages 1450-1457, December 2010